New Rules for Compounding Pharmacies: Best Practices for Compliance
View: 341
Website http://www.onlinecompliancepanel.com?expDate=Ourglocal |
Edit Freely
Category 508 compliance; act compliance; fda compliance; ada compliance; advisor compliance; argent software pci compliance; certificate of compliance; code compliance; compliance; compliance audit; compliance checklist; compliance issues; compliance jobs; compliance management; compliance manager; compliance manual; compliance monitoring; compliance monitoring ppt; compliance officer; compliance plan; compliance plans; compliance program; compliance software; compliance solutions; compliance testing; compliance training; compliance with; contract compliance; corporate compliance; email compliance; environmental compliance; export compliance; health care compliance; healthcare compliance; hipaa compliance; hippa compliance; investment advisor compliance; medical compliance; medication compliance; non compliance; osha compliance; osha compliance training; pci compliance; policy compliance; regulatory compliance; rohs compliance; safety compliance; sarbanes oxley compliance; security compliance; sox compliance; tax comp
Deadline: May 07, 2014 | Date: May 07, 2014
Venue/Country: 38868 Salmon Ter, Fremont, U.S.A
Updated: 2014-04-17 18:40:24 (GMT+9)
Call For Papers - CFP
Instructor: Mukesh KumarDescription:The Drug Quality and Security Act (DQSA), signed into law on the 27 Nov 2013, created new rules for the good manufacturing requirements for compounding pharmacies along with registration requirements and safety reporting obligations. These rules bring compounding pharmacies under more vigorous supervision by giving FDA clearer authority to audit such pharmacies while creating a pathway for compounding pharmacies to voluntarily register with the Agency and sign up to be inspected by the FDA under a new category of FDA-regulated facilities called the "Outsourcing Facility".Within days of the signing of DQSA, FDA released three guidance documents to assist the affected pharmacies with interpreting the law. These rules and guidance documents are expected to also assist prescribers and patients in assuring the quality of the compounded drugs manufactured at a given facility by creating a transparent quality system. This seminar will highlight the key elements of the new rules along with practical suggestions for complying using examples and case studies from past Warning Letters that lead to these rules in the first place. Why Should you Attend:The new rules for compounding pharmacies creates clearer definitions of the drugs that can be compounded, the ingredients that can be used or must be avoided, the facilities and personnel that be involved in compounding of drugs, labeling and shipping requirements, and documentation that must be created and maintained to demonstrate compliance. This seminar will provide a summary of the all the rules along with suggestions to assure high level of compliance. Compliance techniques can be simple and implemented with relative ease leading to better products both in terms of quality and potential benefit to consumers leading to better acceptance. If you are a pharmacy involved in compounding activities for individually identifiable patients or for more broadly used compounded drugs, a physician using compounding pharmacies, or a consumer of such products, this seminar will describe the current federal requirements and strategies to comply. Learning Objectives:Learn how to be compliant with current GMP, registration and reporting requirements for compounding pharmacies operating in the US. Objectives of the Presentation:The conditions under which a compounded product must be producedRaw material sourcing, validation, accountability, and documentation techniquesFacility design and planning issuesDrugs that can or cannot be compoundedFacility registration requirementsType and format of reports required to be submitted periodically to FDAHow do these changes impact products currently in the marketWho can Benefit:This webinar will provide valuable assistance to all personnel in:Compounding PharmaciesPharmacists and other drug handling professionalsRegulatory and Quality Professionals working in compounding pharmaciesHospital and clinics using internal or contract compounding pharmaciesRegulatory, Compliance and Quality Professionals consulting with companies using compounding pharmaciesMedical Insurance and Reimbursement ProfessionalsPhysicians and Consumers using compounded drugshttp://www.onlinecompliancepanel.com/ecommerce/webinar/~product_id=500297?expDate=Ourglocal
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.